Home Journals T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine

T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine

Credits to the Source Link Robert Thimme
T cell immunity to hepatitis C virus: lessons for a prophylactic HCV vaccine
    • Bartenschlager R.
    • Baumert T.F.
    • Bukh J.
    • Houghton M.
    • Lemon S.M.
    • Lindenbach B.D.
    • et al.

    Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies.

    Virus Res. 2018; 248: 53-62

    • Spearman C.W.
    • Dusheiko G.M.
    • Hellard M.
    • Sonderup M.

    Hepatitis C.

    Lancet. 2019; 394: 1451-1466

    • Scott N.
    • Wilson D.P.
    • Thompson A.J.
    • Barnes E.
    • El-Sayed M.
    • Benzaken A.S.
    • et al.

    The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.

    BMC Med. 2019; 17: 175

  • Hepatitis C Vaccine: 10 Good Reasons for Continuing.

    Hepatology. 2020; 71: 1845-1850

    • Pestka J.M.
    • Zeisel M.B.
    • Blaser E.
    • Schurmann P.
    • Bartosch B.
    • Cosset F.L.
    • et al.

    Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C.

    Proc Natl Acad Sci U S A. 2007; 104: 6025-6030

    • Osburn W.O.
    • Fisher B.E.
    • Dowd K.A.
    • Urban G.
    • Liu L.
    • Ray S.C.
    • et al.

    Spontaneous control of primary hepatitis C virus infection and immunity against persistent reinfection.

    Gastroenterology. 2010; 138: 315-324

    • von Delft A.
    • Humphreys I.S.
    • Brown A.
    • Pfafferott K.
    • Lucas M.
    • Klenerman P.
    • et al.

    The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design.

    Gut. 2016; 65: 112-123

  • Innate and adaptive immune responses in HCV infections.

    J Hepatol. 2014; 61: S14-25

  • Immune responses to HCV and other hepatitis viruses.

    Immunity. 2014; 40: 13-24

    • Bailey J.R.
    • Barnes E.
    • Cox A.L.

    Approaches, Progress, and Challenges to Hepatitis C Vaccine Development.

    Gastroenterology. 2019; 156: 418-430

    • Mehta S.H.
    • Cox A.
    • Hoover D.R.
    • Wang X.H.
    • Mao Q.
    • Ray S.
    • et al.

    Protection against persistence of hepatitis C.

    Lancet. 2002; 359: 1478-1483

    • Bassett S.E.
    • Guerra B.
    • Brasky K.
    • Miskovsky E.
    • Houghton M.
    • Klimpel G.R.
    • et al.

    Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection.

    Hepatology. 2001; 33: 1479-1487

    • Major M.E.
    • Mihalik K.
    • Puig M.
    • Rehermann B.
    • Nascimbeni M.
    • Rice C.M.
    • et al.

    Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge.

    J Virol. 2002; 76: 6586-6595

    • Baumert T.F.
    • Fauvelle C.
    • Chen D.Y.
    • Lauer G.M.

    A prophylactic hepatitis C virus vaccine: a distant peak still worth climbing.

    J Hepatol. 2014; 61: S34-44

  • Hepatitis C Vaccines, Antibodies, and T Cells.

    Front Immunol. 2018; 9: 1480

  • Insights From Antiviral Therapy Into Immune Responses to Hepatitis B and C Virus Infection.

    Gastroenterology. 2019; 156: 369-383

  • T cell responses in hepatitis C virus infection: historical overview and goals for future research.

    Antiviral Res. 2015; 114: 96-105

    • Diepolder H.M.
    • Zachoval R.
    • Hoffmann R.M.
    • Jung M.C.
    • Gerlach T.
    • Pape G.R.

    The role of hepatitis C virus specific CD4+ T lymphocytes in acute and chronic hepatitis C.

    J Mol Med. 1996; 74: 583-588

    • Missale G.
    • Bertoni R.
    • Lamonaca V.
    • Valli A.
    • Massari M.
    • Mori C.
    • et al.

    Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response.

    J Clin Invest. 1996; 98: 706-714

    • Thimme R.
    • Oldach D.
    • Chang K.M.
    • Steiger C.
    • Ray S.C.
    • Chisari F.V.

    Determinants of viral clearance and persistence during acute hepatitis C virus infection.

    J Exp Med. 2001; 194: 1395-1406

    • Lechner F.
    • Wong D.K.
    • Dunbar P.R.
    • Chapman R.
    • Chung R.T.
    • Dohrenwend P.
    • et al.

    Analysis of successful immune responses in persons infected with hepatitis C virus.

    J Exp Med. 2000; 191: 1499-1512

    • Cooper S.
    • Erickson A.L.
    • Adams E.J.
    • Kansopon J.
    • Weiner A.J.
    • Chien D.Y.
    • et al.

    Analysis of a successful immune response against hepatitis C virus.

    Immunity. 1999; 10: 439-449

    • Thimme R.
    • Bukh J.
    • Spangenberg H.C.
    • Wieland S.
    • Pemberton J.
    • Steiger C.
    • et al.

    Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease.

    Proc Natl Acad Sci U S A. 2002; 99: 15661-15668

    • Shin E.C.
    • Park S.H.
    • Demino M.
    • Nascimbeni M.
    • Mihalik K.
    • Major M.
    • et al.

    Delayed Induction, Not Impaired Recruitment of Specific CD8(+) T Cells, Causes the Late Onset of Acute Hepatitis C.

    Gastroenterology. 2011;

    • Jo J.
    • Aichele U.
    • Kersting N.
    • Klein R.
    • Aichele P.
    • Bisse E.
    • et al.

    Analysis of CD8+ T-cell-mediated inhibition of hepatitis C virus replication using a novel immunological model.

    Gastroenterology. 2009; 136: 1391-1401

  • Antibody Responses in Hepatitis C Infection.

    Cold Spring Harb Perspect Med. 2020;

    • Luxenburger H.
    • Neumann-Haefelin C.
    • Thimme R.
    • Boettler T.

    HCV-Specific T Cell Responses During and After Chronic HCV Infection.

    Viruses. 2018; 10

    • Kared H.
    • Fabre T.
    • Bedard N.
    • Bruneau J.
    • Shoukry N.H.

    Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.

    PLoS Pathog. 2013; 9e1003422

    • Raziorrouh B.
    • Sacher K.
    • Tawar R.G.
    • Emmerich F.
    • Neumann-Haefelin C.
    • Baumert T.F.
    • et al.

    Virus-Specific CD4+ T Cells Have Functional and Phenotypic Characteristics of Follicular T-Helper Cells in Patients With Acute and Chronic HCV Infections.

    Gastroenterology. 2016; 150 (): 696-706

    • Chen D.Y.
    • Wolski D.
    • Aneja J.
    • Matsubara L.
    • Robilotti B.
    • Hauck G.
    • et al.

    Hepatitis C virus-specific CD4+ T cell phenotype and function in different infection outcomes.

    J Clin Invest. 2020; 130: 768-773

    • Schulze Zur Wiesch J.
    • Ciuffreda D.
    • Lewis-Ximenez L.
    • Kasprowicz V.
    • Nolan B.E.
    • Streeck H.
    • et al.

    Broadly directed virus-specific CD4+ T cell responses are primed during acute hepatitis C infection, but rapidly disappear from human blood with viral persistence.

    J Exp Med. 2012; 209: 61-75

    • Cox A.L.
    • Mosbruger T.
    • Lauer G.M.
    • Pardoll D.
    • Thomas D.L.
    • Ray S.C.

    Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C.

    Hepatology. 2005; 42: 104-112

    • Lauer G.M.
    • Barnes E.
    • Lucas M.
    • Timm J.
    • Ouchi K.
    • Kim A.Y.
    • et al.

    High resolution analysis of cellular immune responses in resolved and persistent hepatitis C virus infection.

    Gastroenterology. 2004; 127: 924-936

    • Gruener N.H.
    • Lechner F.
    • Jung M.C.
    • Diepolder H.
    • Gerlach T.
    • Lauer G.
    • et al.

    Sustained dysfunction of antiviral CD8+ T lymphocytes after infection with hepatitis C virus.

    J Virol. 2001; 75: 5550-5558

    • Takaki A.
    • Wiese M.
    • Maertens G.
    • Depla E.
    • Seifert U.
    • Liebetrau A.
    • et al.

    Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C.

    Nat Med. 2000; 6: 578-582

    • Urbani S.
    • Amadei B.
    • Tola D.
    • Massari M.
    • Schivazappa S.
    • Missale G.
    • et al.

    PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion.

    J Virol. 2006; 80: 11398-11403

    • Kasprowicz V.
    • Schulze Zur Wiesch J.
    • Kuntzen T.
    • Nolan B.E.
    • Longworth S.
    • Berical A.
    • et al.

    High level of PD-1 expression on hepatitis C virus (HCV)-specific CD8+ and CD4+ T cells during acute HCV infection, irrespective of clinical outcome.

    J Virol. 2008; 82: 3154-3160

    • Shin E.C.
    • Park S.H.
    • Nascimbeni M.
    • Major M.
    • Caggiari L.
    • de Re V.
    • et al.

    The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection.

    J Virol. 2013; 87: 4772-4777

    • Golden-Mason L.
    • Burton Jr., J.R.
    • Castelblanco N.
    • Klarquist J.
    • Benlloch S.
    • Wang C.
    • et al.

    Loss of IL-7 receptor alpha-chain (CD127) expression in acute HCV infection associated with viral persistence.

    Hepatology. 2006; 44: 1098-1109

    • Kurktschiev P.D.
    • Raziorrouh B.
    • Schraut W.
    • Backmund M.
    • Wachtler M.
    • Wendtner C.M.
    • et al.

    Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.

    J Exp Med. 2014; 211: 2047-2059

    • Bengsch B.
    • Seigel B.
    • Ruhl M.
    • Timm J.
    • Kuntz M.
    • Blum H.E.
    • et al.

    Coexpression of PD-1, 2B4, CD160 and KLRG1 on exhausted HCV-specific CD8+ T cells is linked to antigen recognition and T cell differentiation.

    PLoS Pathog. 2010; 6e1000947

    • Wolski D.
    • Foote P.K.
    • Chen D.Y.
    • Lewis-Ximenez L.L.
    • Fauvelle C.
    • Aneja J.
    • et al.

    Early Transcriptional Divergence Marks Virus-Specific Primary Human CD8(+) T Cells in Chronic versus Acute Infection.

    Immunity. 2017; 47: 648-663 e648

    • Barili V.
    • Fisicaro P.
    • Montanini B.
    • Acerbi G.
    • Filippi A.
    • Forleo G.
    • et al.

    Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.

    Nat Commun. 2020; 11: 604

    • Abdel-Hakeem M.S.
    • Bedard N.
    • Murphy D.
    • Bruneau J.
    • Shoukry N.H.

    Signatures of protective memory immune responses during hepatitis C virus reinfection.

    Gastroenterology. 2014; 147: 870-881 e878

    • Grakoui A.
    • Shoukry N.H.
    • Woollard D.J.
    • Han J.H.
    • Hanson H.L.
    • Ghrayeb J.
    • et al.

    HCV persistence and immune evasion in the absence of memory T cell help.

    Science. 2003; 302: 659-662

    • Shoukry N.H.
    • Grakoui A.
    • Houghton M.
    • Chien D.Y.
    • Ghrayeb J.
    • Reimann K.A.
    • et al.

    Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection.

    J Exp Med. 2003; 197: 1645-1655

    • Bukh J.
    • Thimme R.
    • Meunier J.C.
    • Faulk K.
    • Spangenberg H.C.
    • Chang K.M.
    • et al.

    Previously infected chimpanzees are not consistently protected against reinfection or persistent infection after reexposure to the identical hepatitis C virus strain.

    J Virol. 2008; 82: 8183-8195

    • Blank C.U.
    • Haining W.N.
    • Held W.
    • Hogan P.G.
    • Kallies A.
    • Lugli E.
    • et al.

    Defining ‘T cell exhaustion’.

    Nat Rev Immunol. 2019; 19: 665-674

    • Penna A.
    • Pilli M.
    • Zerbini A.
    • Orlandini A.
    • Mezzadri S.
    • Sacchelli L.
    • et al.

    Dysfunction and functional restoration of HCV-specific CD8 responses in chronic hepatitis C virus infection.

    Hepatology. 2007; 45: 588-601

    • Radziewicz H.
    • Ibegbu C.C.
    • Fernandez M.L.
    • Workowski K.A.
    • Obideen K.
    • Wehbi M.
    • et al.

    Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression.

    J Virol. 2007; 81: 2545-2553

    • Nakamoto N.
    • Cho H.
    • Shaked A.
    • Olthoff K.
    • Valiga M.E.
    • Kaminski M.
    • et al.

    Synergistic reversal of intrahepatic HCV-specific CD8 T cell exhaustion by combined PD-1/CTLA-4 blockade.

    PLoS Pathog. 2009; 5e1000313

    • Wieland D.
    • Kemming J.
    • Schuch A.
    • Emmerich F.
    • Knolle P.
    • Neumann-Haefelin C.
    • et al.

    TCF1(+) hepatitis C virus-specific CD8(+) T cells are maintained after cessation of chronic antigen stimulation.

    Nat Commun. 2017; 8: 15050

    • Utzschneider D.T.
    • Charmoy M.
    • Chennupati V.
    • Pousse L.
    • Ferreira D.P.
    • Calderon-Copete S.
    • et al.

    T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections.

    Immunity. 2016; 45: 415-427

    • Khan O.
    • Giles J.R.
    • McDonald S.
    • Manne S.
    • Ngiow S.F.
    • Patel K.P.
    • et al.

    TOX transcriptionally and epigenetically programs CD8(+) T cell exhaustion.

    Nature. 2019; 571: 211-218

    • Alfei F.
    • Kanev K.
    • Hofmann M.
    • Wu M.
    • Ghoneim H.E.
    • Roelli P.
    • et al.

    TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection.

    Nature. 2019; 571: 265-269

    • Kroy D.C.
    • Ciuffreda D.
    • Cooperrider J.H.
    • Tomlinson M.
    • Hauck G.D.
    • Aneja J.
    • et al.

    Liver environment and HCV replication affect human T-cell phenotype and expression of inhibitory receptors.

    Gastroenterology. 2014; 146: 550-561

  • Hepatic immune regulation and its involvement in viral hepatitis infection.

    Gastroenterology. 2014; 146: 1193-1207

    • Erickson A.L.
    • Kimura Y.
    • Igarashi S.
    • Eichelberger J.
    • Houghton M.
    • Sidney J.
    • et al.

    The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes.

    Immunity. 2001; 15: 883-895

    • Chang K.M.
    • Rehermann B.
    • McHutchison J.G.
    • Pasquinelli C.
    • Southwood S.
    • Sette A.
    • et al.

    Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus.

    J Clin Invest. 1997; 100: 2376-2385

    • Timm J.
    • Lauer G.M.
    • Kavanagh D.G.
    • Sheridan I.
    • Kim A.Y.
    • Lucas M.
    • et al.

    CD8 epitope escape and reversion in acute HCV infection.

    J Exp Med. 2004; 200: 1593-1604

    • Neumann-Haefelin C.
    • Timm J.
    • Spangenberg H.C.
    • Wischniowski N.
    • Nazarova N.
    • Kersting N.
    • et al.

    Virological and immunological determinants of intrahepatic virus-specific CD8+ T-cell failure in chronic hepatitis C virus infection.

    Hepatology. 2008; 47: 1824-1836

    • Kasprowicz V.
    • Kang Y.H.
    • Lucas M.
    • Schulze zur Wiesch J.
    • Kuntzen T.
    • Fleming V.
    • et al.

    Hepatitis C virus (HCV) sequence variation induces an HCV-specific T-cell phenotype analogous to spontaneous resolution.

    J Virol. 2010; 84: 1656-1663

    • Neumann-Haefelin C.
    • McKiernan S.
    • Ward S.
    • Viazov S.
    • Spangenberg H.C.
    • Killinger T.
    • et al.

    Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution.

    Hepatology. 2006; 43: 563-572

    • Kim A.Y.
    • Kuntzen T.
    • Timm J.
    • Nolan B.E.
    • Baca M.A.
    • Reyor L.L.
    • et al.

    Spontaneous control of HCV is associated with expression of HLA-B 57 and preservation of targeted epitopes.

    Gastroenterology. 2011; 140: 686-696 e681

    • Fitzmaurice K.
    • Petrovic D.
    • Ramamurthy N.
    • Simmons R.
    • Merani S.
    • Gaudieri S.
    • et al.

    Molecular footprints reveal the impact of the protective HLA-A*03 allele in hepatitis C virus infection.

    Gut. 2011;

    • Dazert E.
    • Neumann-Haefelin C.
    • Bressanelli S.
    • Fitzmaurice K.
    • Kort J.
    • Timm J.
    • et al.

    Loss of viral fitness and cross-recognition by CD8+ T cells limit HCV escape from a protective HLA-B27-restricted human immune response.

    J Clin Invest. 2009; 119: 376-386

    • von Delft A.
    • Donnison T.A.
    • Lourenco J.
    • Hutchings C.
    • Mullarkey C.E.
    • Brown A.
    • et al.

    The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes.

    Vaccine. 2018; 36: 313-321

    • Raziorrouh B.
    • Ulsenheimer A.
    • Schraut W.
    • Heeg M.
    • Kurktschiev P.
    • Zachoval R.
    • et al.

    Inhibitory molecules that regulate expansion and restoration of HCV-specific CD4+ T cells in patients with chronic infection.

    Gastroenterology. 2011; 141 (): 1422-1431

    • Ackermann C.
    • Smits M.
    • Woost R.
    • Eberhard J.M.
    • Peine S.
    • Kummer S.
    • et al.

    HCV-specific CD4+ T cells of patients with acute and chronic HCV infection display high expression of TIGIT and other co-inhibitory molecules.

    Sci Rep. 2019; 9: 10624

    • Fuller M.J.
    • Shoukry N.H.
    • Gushima T.
    • Bowen D.G.
    • Callendret B.
    • Campbell K.J.
    • et al.

    Selection-driven immune escape is not a significant factor in the failure of CD4 T cell responses in persistent hepatitis C virus infection.

    Hepatology. 2010; 51: 378-387

    • Fleming V.M.
    • Harcourt G.
    • Barnes E.
    • Klenerman P.

    Virological footprint of CD4+ T-cell responses during chronic hepatitis C virus infection.

    J Gen Virol. 2010; 91: 1396-1406

    • Lucas M.
    • Deshpande P.
    • James I.
    • Rauch A.
    • Pfafferott K.
    • Gaylard E.
    • et al.

    Evidence of CD4(+) T cell-mediated immune pressure on the Hepatitis C virus genome.

    Sci Rep. 2018; 8: 7224

    • Boettler T.
    • Spangenberg H.C.
    • Neumann-Haefelin C.
    • Panther E.
    • Urbani S.
    • Ferrari C.
    • et al.

    T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.

    J Virol. 2005; 79: 7860-7867

    • Cabrera R.
    • Tu Z.
    • Xu Y.
    • Firpi R.J.
    • Rosen H.R.
    • Liu C.
    • et al.

    An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.

    Hepatology. 2004; 40: 1062-1071

    • Sugimoto K.
    • Ikeda F.
    • Stadanlick J.
    • Nunes F.A.
    • Alter H.J.
    • Chang K.M.

    Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection.

    Hepatology. 2003; 38: 1437-1448

    • Martin B.
    • Hennecke N.
    • Lohmann V.
    • Kayser A.
    • Neumann-Haefelin C.
    • Kukolj G.
    • et al.

    Restoration of HCV-specific CD8+ T cell function by interferon-free therapy.

    J Hepatol. 2014; 61: 538-543

    • Callendret B.
    • Eccleston H.B.
    • Hall S.
    • Satterfield W.
    • Capone S.
    • Folgori A.
    • et al.

    T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.

    Hepatology. 2014; 60: 1531-1540

    • Aregay A.
    • Owusu Sekyere S.
    • Deterding K.
    • Port K.
    • Dietz J.
    • Berkowski C.
    • et al.

    Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses.

    J Hepatol. 2019; 71: 889-899

    • Abdel-Hakeem M.S.
    • Bedard N.
    • Badr G.
    • Ostrowski M.
    • Sekaly R.P.
    • Bruneau J.
    • et al.

    Comparison of immune restoration in early versus late alpha interferon therapy against hepatitis C virus.

    J Virol. 2010; 84: 10429-10435

    • Utzschneider D.T.
    • Legat A.
    • Fuertes Marraco S.A.
    • Carrie L.
    • Luescher I.
    • Speiser D.E.
    • et al.

    T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion.

    Nat Immunol. 2013; 14: 603-610

    • Kelly C.
    • Swadling L.
    • Capone S.
    • Brown A.
    • Richardson R.
    • Halliday J.
    • et al.

    Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.

    Hepatology. 2016; 63: 1455-1470

    • Callendret B.
    • Eccleston H.B.
    • Satterfield W.
    • Capone S.
    • Folgori A.
    • Cortese R.
    • et al.

    Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.

    Hepatology. 2016; 63: 1442-1454

    • Hartnell F.
    • Esposito I.
    • Swadling L.
    • Brown A.
    • Phetsouphanh C.
    • de Lara C.
    • et al.

    Characterising HCV specific CD4+ T-cells following viral-vectored vaccination, directly acting anti-virals and spontaneous viral cure.

    Hepatology. 2020;

    • Langhans B.
    • Nischalke H.D.
    • Kramer B.
    • Hausen A.
    • Dold L.
    • van Heteren P.
    • et al.

    Increased peripheral CD4(+) regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C.

    J Hepatol. 2017; 66: 888-896

    • Smits M.
    • Zoldan K.
    • Ishaque N.
    • Gu Z.
    • Jechow K.
    • Wieland D.
    • et al.

    Follicular T helper cells shape the HCV-specific CD4+ T cell repertoire after virus elimination.

    J Clin Invest. 2020; 130: 998-1009

    • Folgori A.
    • Capone S.
    • Ruggeri L.
    • Meola A.
    • Sporeno E.
    • Ercole B.B.
    • et al.

    A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees.

    Nat Med. 2006; 12: 190-197

    • Park S.H.
    • Shin E.C.
    • Capone S.
    • Caggiari L.
    • De Re V.
    • Nicosia A.
    • et al.

    Successful vaccination induces multifunctional memory T-cell precursors associated with early control of hepatitis C virus.

    Gastroenterology. 2012; 143 (): 1048-1060

    • Drane D.
    • Maraskovsky E.
    • Gibson R.
    • Mitchell S.
    • Barnden M.
    • Moskwa A.
    • et al.

    Priming of CD4+ and CD8+ T cell responses using a HCV core ISCOMATRIX vaccine: a phase I study in healthy volunteers.

    Hum Vaccin. 2009; 5: 151-157

    • Mally A.
    • Walker C.L.
    • Everitt J.I.
    • Dekant W.
    • Vamvakas S.

    Analysis of renal cell transformation following exposure to trichloroethene in vivo and its metabolite S-(dichlorovinyl)-L-cysteine in vitro.

    Toxicology. 2006; 224: 108-118

    • Swadling L.
    • Capone S.
    • Antrobus R.D.
    • Brown A.
    • Richardson R.
    • Newell E.W.
    • et al.

    A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

    Sci Transl Med. 2014; 6 ()

    • Barnes E.
    • Folgori A.
    • Capone S.
    • Swadling L.
    • Aston S.
    • Kurioka A.
    • et al.

    Novel adenovirus-based vaccines induce broad and sustained T cell responses to HCV in man.

    Sci Transl Med. 2012; 4 ()

    • Cox A.L.
    • Page K.
    • Melia M.
    • Veenhuis R.
    • Massaccesi G.
    • Osburn W.
    • et al.

    LB10. A Randomized, Double-Blind, Placebo-Controlled Efficacy Trial of a Vaccine to Prevent Chronic Hepatitis C Virus Infection in an at-Risk Population.

    Open Forum Infectious Diseases. 2019; 6 ()

    • Kelly C.
    • Swadling L.
    • Brown A.
    • Capone S.
    • Folgori A.
    • Salio M.
    • et al.

    Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.

    Eur J Immunol. 2015; 45: 309-316

    • Billerbeck E.
    • Wolfisberg R.
    • Fahnoe U.
    • Xiao J.W.
    • Quirk C.
    • Luna J.M.
    • et al.

    Mouse models of acute and chronic hepacivirus infection.

    Science. 2017; 357: 204-208

  • Animal Models of Hepatitis C Virus Infection.

    Cold Spring Harb Perspect Med. 2020; 10

  • Source Link

    Related Articles

    Leave a Comment

    This website uses cookies to improve your experience. We will assume you are ok with this, but you can opt-out if you wish. Accept Read More

    %d bloggers like this: